Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Androgen receptor antagonist 4 (Compound AT2) has anticancer activities. Androgen receptor antagonist 4 potently antagonizes the activity of AR transcriptional, inhibits downstream target gene of AR, and blocks the DHT-induced nuclear translocation of AR. Androgen receptor antagonist 4 is an antagonist of androgen receptor (AR) (IC 50 = 0.15 μM) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 2,140.00 | |
50 mg | 6-8 weeks | $ 2,785.00 | |
100 mg | 6-8 weeks | $ 3,520.00 |
Description | Androgen receptor antagonist 4 (Compound AT2) has anticancer activities. Androgen receptor antagonist 4 potently antagonizes the activity of AR transcriptional, inhibits downstream target gene of AR, and blocks the DHT-induced nuclear translocation of AR. Androgen receptor antagonist 4 is an antagonist of androgen receptor (AR) (IC 50 = 0.15 μM) [1]. |
Molecular Weight | 331.84 |
Formula | C22H18ClN |
CAS No. | 354815-43-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Androgen receptor antagonist 4 354815-43-3 inhibitor inhibit